LDLR and ischemia: In addition, inhibitors of PHDs provided protection against atherosclerosis in LDL receptor-deficient mice [49], and improved post-ischemia myocardial dysfunction [38] and renal metabolic abnormalities [50,51] in experimental models of diabetes.